Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2012
05/10/2012WO2012061075A2 Hiv resistant and functional hematopoietic stem/progenitor cells and macrophages from induced pluripotent stem cells
05/10/2012WO2012060790A2 Water dispersible cefpodoxime proxetil formulations
05/10/2012WO2012060738A1 CLATHRATE COMPLEXES OF β-CYCLODEXTRIN WITH 1-{[6-BROMO-1-METHYL-5-METHOXY-2-PHENYLTHIOMETHYL-1-H-INDOLE-3-YL]CARBONYL}-4-BENZYLPIPERAZINE HAVING ANTIVIRAL ACTIVITY, THE PRODUCTION AND USE THEREOF
05/10/2012WO2012060448A1 Combined pharmaceutical composition as antifungal agent
05/10/2012WO2012060312A1 Vegetable lactic acid bacterium isolated from rice hull or hulled rice and utilization of same
05/10/2012WO2012059570A1 USE OF ATOMIC QUANTUM CLUSTERS (AQCs) IN THE PREVENTION OF VIRAL INFECTIONS
05/10/2012WO2012058795A1 Uses of unsaturated fatty acids for inhibiting virus replication and /or infection
05/10/2012WO2012033858A3 Benzoxaborole derivatives for treating bacterial infections
05/10/2012WO2012032360A3 Novel use
05/10/2012WO2012027200A3 Epitope therapy for infectious diseases
05/10/2012WO2012021578A8 Use of angiotensin- ii (1-7) in cell transplantation and as an agent for preventing/treating norovirus infection
05/10/2012WO2012020021A9 Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases
05/10/2012WO2012009712A3 Methods and compositions including spore-forming bacteria for increasing the health of animals
05/10/2012WO2011146624A9 Methods of treating recurring bacterial infection
05/10/2012WO2011146439A3 Identifying antifungal agents that inhibit iaa or a yap family member
05/10/2012US20120115954 Aqueous retinoid and benzoyl peroxide gel
05/10/2012US20120115940 Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis
05/10/2012US20120115918 Anti-Viral Compounds
05/10/2012US20120115916 Oxazole and thiazole derivatives as alx receptor agonists
05/10/2012US20120115915 N,n'-diarylurea compounds and n,n'-diarylthiourea compounds as inhibitors of translation initiation
05/10/2012US20120115905 Nitrone, Nitroso, and Nitroxide Spintraps and Spin Labels and Their Hydroxylamines
05/10/2012US20120115904 Compounds having antiparasitic or anti-infectious activity
05/10/2012US20120115903 Substituted Heteroaromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115902 3H-Imidazo [4, 5-B] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
05/10/2012US20120115899 Naphthyridin-2 (1 h)-one compounds useful as antibacterials
05/10/2012US20120115893 Substituted Bicyclic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115876 N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones
05/10/2012US20120115875 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
05/10/2012US20120115861 Aminopyridine derivatives for treating tumors and inflammatory diseases
05/10/2012US20120115857 Novel Polymorphs of Efavirenz
05/10/2012US20120115855 Inhibitors of hcv ns5a
05/10/2012US20120115847 Compounds for the Treatment of Hepatitis C
05/10/2012US20120115846 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof.
05/10/2012US20120115841 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
05/10/2012US20120115836 Stable liquid formulations of anti-infective agents and adjusted anti-infective agent dosing regimens
05/10/2012US20120115835 Methods for treatment of bacterial infections
05/10/2012US20120115828 Medicinal cream containing miconazole nitrate, hydrocortisone acetate, and a biopolymer, and a process to make it
05/10/2012US20120115827 3-aminobenzamide compounds and vanilloid receptor subtype 1 (vr1) inhibitors
05/10/2012US20120115825 Cyclohexyloxy-substituted heterocyclics, medicines containing these compounds and method for the production thereof
05/10/2012US20120115824 Vitamin D Receptor Agonists and Uses Thereof
05/10/2012US20120115821 Composition and method for treating skin conditions
05/10/2012US20120115819 Pentacycline Compounds
05/10/2012US20120115818 Synthesis of tetracyclines and intermediates thereto
05/10/2012US20120115813 Boron-containing small molecules
05/10/2012US20120115807 Combination of alovudine and zidovudine in a molar ratio of 1:100 to 1:350
05/10/2012US20120115803 Treatment of acinetobacter with alginate oligomers and antibiotics
05/10/2012US20120115801 Method for obtaining a stable dispersion of benzoyl peroxide
05/10/2012US20120115775 Mutant tat proteins and uses thereof
05/10/2012US20120115774 Antimicrobial cationic lipo-beta-peptides
05/10/2012US20120115136 Pna diagnostic use
05/10/2012US20120114762 Physico-Chemical-Managed Killing of Penicillin-Resistant Static and Growing Gram-Positive and Gram-Negative Vegetative Bacteria
05/10/2012US20120114760 Compositions for treating wounds and processes for their preparation
05/10/2012US20120114756 Sustained-release drug carrier composition
05/10/2012US20120114751 Pharmaceutical composition for treating hcv infections
05/10/2012US20120114746 Immunostimulatory Compositions Comprising Liposome-Encapsulated Oligonucleotides and Epitopes
05/10/2012US20120114745 Method for treating or ameliorating mucocutaneous or ocular toxicities
05/10/2012US20120114743 Transdermal ricinoleic acid compositions
05/10/2012US20120114742 Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof
05/10/2012US20120114737 Silicone acrylate hybrid composition and method of making same
05/10/2012US20120114731 Multilayer protein films, methods of making, and drug delivery devices and biomedical implants employing the films
05/10/2012US20120114716 Flowable Carrier Matrix
05/10/2012US20120114702 Compositions and methods for treating asthma and other lung disorders
05/10/2012US20120114701 Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
05/10/2012US20120114700 Lat adapter molecule for enhanced t-cell signaling and method of use
05/10/2012US20120114696 Small-molecule botulinum toxin inhibitors
05/10/2012US20120114695 Hsv-1 and hsv-2 vaccines and methods of use thereof
05/10/2012US20120114694 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
05/10/2012US20120114693 Nucleic acid mucosal immunization
05/10/2012US20120114692 Immunogenic compositions containing phospholipid
05/10/2012US20120114691 Vaccine against african horse sickness virus
05/10/2012US20120114687 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
05/10/2012US20120114686 Compositions and methods related to protein a (spa) variants
05/10/2012US20120114684 Compounds and methods for treatment and diagnosis of chlamydial infection
05/10/2012US20120114683 Nucleic Acid Encoding TGEV and PRRSV Sequences for Improved Expression of PRRSV Sequences
05/10/2012US20120114679 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/10/2012US20120114674 Molecular Antigen Array
05/10/2012US20120114664 Antibodies against h5n1 strains of influenza a virus
05/10/2012US20120114662 Human monoclonal antibodies against bacillus anthracis protective antigen
05/10/2012US20120114661 Methods of identifying infectious disease and assays for identifying infectious disease
05/10/2012US20120114656 Human Monoclonal Antibodies Protective Against Bubonic Plague
05/10/2012US20120114649 Compositions of pd-1 antagonists and methods of use
05/10/2012US20120114648 Compositions of pd-1 antagonists and methods of use
05/10/2012US20120114639 Compositions and methods for inhibiting viral and/or bacterial infections
05/10/2012US20120114633 Inhibitors Of Bacterial Type III Secretion System
05/10/2012US20120114611 Bacteriophage-containing therapeutic agents
05/10/2012US20120114604 Combinations for HCV Treatment
05/10/2012US20120114602 Process for the synthesis of conjugates of glycosaminoglycanes (gag) with biologically active molecules, polymeric conjugates and relative uses thereof
05/10/2012US20120114601 New isothiazoloquinolones and related compounds as anti-infective agents
05/10/2012US20120114600 Novel inhibitors of hepatitis c virus
05/10/2012US20120114599 Opioid and opioid-like compounds and uses thereof
05/10/2012US20120114596 Tslp promotes immune evasion and persistence of viruses
05/10/2012US20120114591 Treatment of chronic ulcerous skin lesions
05/10/2012US20120114590 Il28 and il29 truncated cysteine mutants and antiviral methods of using same
05/10/2012US20120114574 Compositions for nail and skin treatment
05/10/2012US20120114568 Beeswax and jojoba wax emulsion
05/10/2012US20120114567 Oral compositions containing oxidized camellia
05/10/2012US20120114558 Aptamer-mediated drug release
05/10/2012US20120114556 Immunotherapy of autoimmune disorders using antibodies which target b-cells
05/10/2012DE102010050558A1 1H-Pyrrolo[2,3-b]pyridinderivate 1H-pyrrolo [2,3-b] pyridine
05/10/2012DE102010050299A1 New organisms, e.g. bacteria, which live in the human body and produce substances, e.g. as waste product, which blocks the receptor molecules from the HIV virus, and no longer docks the HIV virus, useful e.g. for the production of insulin
1 ... 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 ... 1798